Genetic editing tech CRISPR comes to UH, gets $149K boost … – University of Hawaii

Students learning how to perform digital PCR to analyze copy numbers of transformants

University of Hawaii at Mnoa Assistant Professor Zhi-Yan Rock Du from the Department of Molecular Biosciences and Bioengineering (MBBE) has received a $149,000 grant from the USDAs National Institute of Food and Agriculture to jumpstart a project that will introduce the UH System to CRISPR, the basis of genetic editing technology.

Motivated to educate Hawaiis current and future workforce in this cutting-edge technologyand to better represent Native Hawaiians and other Pacific Islanders in science and technology disciplinesDu has initiated the first official CRISPR laboratory course at UH Mnoa, in addition to CRISPR workshops for baccalaureate and two-year postsecondary students within the UH System.

This education project will address the educational disparities and needs of curriculum development, instructional delivery systems and expand student career opportunities, said Du. The long-term goal of this project is to develop agricultural and science literacy in Hawaii by building competencies in molecular biology, genetics, biotechnology, agricultural science and science communication.

Du and his graduate students and teaching assistants conducted an MBBE/BIOL 401Lab Molecular Biotechnology Lab-Gene Editing by CRISPR/Cas9 in spring 2023 and have also planned workshops in summer and fall, with the first workshop to launch in July 2023. Students will also utilize materials such as tropical maize from a current research project for this new education opportunity.

In the past decade, CRISPR genetic engineering tools have become an essential technology in numerous industries, including food and agriculture, drug development and therapy, as well as ongoing scientific research; however, Du said that CRISPR systems are not well understood in the general community, leading to fears and misunderstandings about genetic engineering and an overall anti-science outlook.

Hawaii is heavily dependent on food imports, said Du. Its urgent to simulate local agriculture and workforce development. The grant will promote the education of college students on novel non-transgenic genome editing technologies, such as CRISPR/Cas RNP (ribonucleoprotein) with gene gun/particle bombardment methods. Students will learn and practice the new genome-editing technologies. We hope to engage more students from UH Mnoa and other campuses, including community colleges, in food and agricultural careers for our future food security and quality.

Read more at the CTAHR website.

Continue reading here:
Genetic editing tech CRISPR comes to UH, gets $149K boost ... - University of Hawaii

Illumina’s Surge in Stocks Signals Growing Investor Interest in … – Best Stocks

In recent news, Handelsbanken Fonder AB has increased their holdings in Illumina, Inc. by 10.1% during the fourth quarter of this year. The life sciences company has made significant strides to remain competitive in the market thanks to its strong commitment to research and development in genetics. This recent surge in stocks goes to show that investors have a growing interest in this field as they continue to recognize Illuminas potential for growth.

Illuminas financial report for Q3 demonstrates their positive progress. They have reported earnings per share (EPS) of $0.08 for this quarter, exceeding analysts expectations by $0.06. Although the company had incurred a negative net margin of 100.92%, it still managed to achieve a positive return on equity of 2.26%. Moreover, the business garnered revenue amounting to $1.09 billion, surpassing predicted sales figures by hitting $1.07 billion with an 11% decrease compared to the previous year.

Illumina invests extensively not only in developing advanced technology for genetic research but also integrating these systems into life science tools beneficial across several fields such as clinical and applied markets, therefore enabling adoption to multifarious genomic solutions through its Core Illumina segment.

As genetics is proving to be an increasingly crucial component of healthcare and medical research today, companies like Illumina are poised for colossal growth in the future stemming from advancements in genetic therapies or cures that may arise later on due to innovations occurring within recently unearthed non-coding regions throughout the DNA landscape.

With intensive R&D efforts ongoing underpinning various aspects of genomic study while continuing to develop, manufacture, and market tools integrated with life science systems geared towards large-scale analysis of genetic variation and function Illumina remains at the forefront of industry leaders driving change through innovation regarding gene therapy treatments designed for an entirely new era hoping ultimately to inspire curative effects across multiple disease states.

Illumina, Inc. is a reputable life science company that develops, manufactures, and markets genetic variation and functional analysis tools for large-scale use. Recently, several institutional investors have added to or reduced their stakes in Illumina, including Acadian Asset Management LLC, which raised its holdings by 312.5% during the first quarter. Other investors such as Dimensional Fund Advisors LP, Dakota Wealth Management, Sequoia Financial Advisors LLC, and Baird Financial Group Inc also increased their positions last quarter.

The firm operates through the Core Illumina segment that enables adoption of genomic solutions serving customers in various fields like research, clinical and applied markets. Shares of NASDAQ:ILMN opened at $202.31 on Tuesday with a market cap of $31.98 billion. The stocks 50-day moving average price is $218.04 with a two-hundred day moving average price at $213.87. The 12-month high is $309.12 while the low stands at $173.45.

An SVP Alexander Aravanis sold 5,398 shares of Illumina stock while Aimee L Hoyt sold 3,917 shares recently in separate transactions totaling up to 9,815 shares of company stock worth $1,974,496 in the past ninety days.Several equities analysts issued reports on ILMN shares in recent times with Argus cutting down its rating from buy to hold in January due to valuation reasoning while Barclays reduced their price target on shares from $160 to $150 and rated it as underweight.

Overall investor outlook on Illumina seems mixed as two equities research analysts rate the stock as sell while seven assign a hold rating and eight issue buy ratings according to Bloomberg.com making it average towards holding.Despite this fluctuating investment performance pattern over time associated with genome sequencing firms due to diverse reasons including liability issues faced by personal genomics companies that provided DNA tests, the constantly evolving industry holds promise in application within healthcare settings, personalized nutrition, and genetics making Illumina a promising holding for what appears will be an uncharted market of genetic solutions.

Read the rest here:
Illumina's Surge in Stocks Signals Growing Investor Interest in ... - Best Stocks

Myriad Genetics to Participate in BofA Securities Healthcare Conference – Myriad Genetics (NASDAQ:MYGN) – Benzinga

May 2, 2023 4:05 PM | 1 min read

SALT LAKE CITY, May 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it will be participating in the upcoming BofA Securities Healthcare Conference in Las Vegas, NV.

Myriad management will participate in a fireside chat on Tuesday, May 9 at 3:00 p.m. PT. A live and archived webcast of the presentation can be viewed in the investor relations section of Myriad's website at http://www.myriad.com.

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

About Myriad GeneticsMyriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit http://www.myriad.com.

The Best Report Benzinga Has Ever Produced

Massive returns are within possible within this market! For a limited time, get access to the Benzinga Insider Report, usually $47/month, for just $0.99! Discover extremely undervalued stock picks before they skyrocket! Time is running out! Act fast and secure your future wealth at this unbelievable discount!

Claim your $0.99 offer NOW!

2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

See the article here:
Myriad Genetics to Participate in BofA Securities Healthcare Conference - Myriad Genetics (NASDAQ:MYGN) - Benzinga

3000-year-old ‘bear’ bone from Alaska isn’t what it seems – Livescience.com

A 3,000-year-old bone unearthed from a cave in southeastern Alaska is not from a bear, as originally thought, but from one of our own a woman. And new research reveals that her genetics are essentially the same as the Native American people who live in the region now.

The 1.2-inch-long (3 centimeters) bone fragment was discovered in the 1990s in Lawyer's Cave on the Alaskan mainland, east of Wrangell Island in the Alexander Archipelago.

It was found near shell beads and a bone awl, which indicated that the cave was inhabited by prehistoric humans at some point. But scientists thought the bone was from an animal perhaps a bear that had been hunted by Native Americans at that time.

The bone fragment seems to have been kept in an archive until 2019, when it arrived in a laboratory at the University at Buffalo in New York. Once there, genetic tests showed that the bone once thought to be from a prehistoric bear was actually from a prehistoric human.

"I was very excited," Alber Aqil (opens in new tab), a doctoral student of biological sciences at the University at Buffalo who made the discovery, told Live Science. "I had just come to the department, and this was my first project."

Related: 10 amazing things we learned about our human ancestors in 2022

Research on the fragment revealed it is part of the humerus, or upper arm bone, of a Native American woman who lived about 3,000 years ago. After consulting local tribal authorities, Aqil and his colleagues dubbed the woman "Tatok yk yes shawat" in the Tlingit language, or "young lady in cave," according to the study, published in the May issue of the journal iScience (opens in new tab).

Only about 15% of the prehistoric woman's genome could be extracted from the bone, Aqil said; but it was enough to determine that the genetics of Tatok yk yes shawat are the same as the Tlingit people and related Native American peoples who still live in the region today.

"I would say that the Tlingit people have been where they are for a [very] long time," he said.

Aqil explained that scientists now believe Native Americans entered North America from Siberia in three waves. The first, of all non-Inuit Indigenous people, occurred about 23,000 years ago (opens in new tab) over the Beringia Land Bridge. A second wave, via the sea about 6,000 years ago (opens in new tab), saw the Paleo-Inuit peoples arrive in the region: and possibly a third wave, again by sea, occurred between about 2,000 and 1,000 (opens in new tab) years ago, when the Neo-Inuit peoples arrived.

The genetics of "young lady in cave," however, are not seen in ancient DNA from the Paleo-Inuit people; and so it seems "Tatok yk yes shawat" or TYYS, as she's now known for short was a descendant of people who came in the first wave, he said.

Neither the TYYS genome nor the handful of other ancient Alaskan human genomes show any sign that the people in the first migration interbred with Paleo-Inuits at any time: "It has been claimed before that there was interbreeding between people in the first two waves, but we could not find any evidence for it," Aqil said.

The next stage of the project would be to return the bone fragment to representatives of the Indigenous peoples of southeastern Alaska, so that it could be reburied as a fragment of an ancestor with appropriate ceremonies, he said.

The rest is here:
3000-year-old 'bear' bone from Alaska isn't what it seems - Livescience.com

Health officials address spike in pediatric brain abscess cases, still considered ‘rare’ – News3LV

Health officials address spike in pediatric brain abscess cases, still considered 'rare'

Cases of pediatric brain abscesses increased nearly threefold in 2022, according to the Southern Nevada Health District (SNHD).

On average, Clark County would have approximately five cases a year, but that number jumped to 18 last year. The sharp increase triggered a Centers for Disease Control (CDC) investigation and public health advisory from the SNHD.

Dr. Taryn Bragg is the only pediatric neurosurgeon in the state of Nevada. Because of that distinction, she was the first to treat all of the patients and noticed a pattern emerge. She recalled the CDC had been investigating similar increases in other states and asked them to investigate in Southern Nevada as well.

The findings were presented last Thursday at the CDC's Epidemic Intelligence Service Conference, as first reported by CNN.

"This is not the typical cold. This is not 'I have a mild headache. I have a low-grade fever. I might have some drainage from my nose.' This is severe symptoms, severe headache, lethargy, seizures, weakness, they may have even noticed swelling in the face or in the eyes," said Dr. Bragg. "And so these are things that are not subtle, you're not going to miss it."

Dr. Bragg said it was easy to detect an increase once she had eleven cases in a four or five-month period beginning Spring 2022. She wanted pediatric providers across Nevada to know about this increase so that they might consider imaging or increasing treatment for children who were showing symptoms of sinus or ear infections.

Dean Marc J Kahn with the Kirk Kerkorian School of Medicine in Las Vegas said the increase to 18 cases meant it's still a rare occurrence, but that it warranted some scrutiny.

"The case numbers are small. We don't know why we've seen this spike in cases, although they have gone down over the past several weeks, two months," said Dr. Kahn. "For parents, I think this is an unusual event. I think that, again, we want our kids to be vaccinated, and up to date on vaccinations. We want our kids to eat healthy, and we want them to be healthy."

Brain abscesses occur when bacteria or fungi that circulate in the blood get to the brain, causing an infection in the brain, Kahn said. When that happens, inflammatory cells fight the infection and create a walled off cavity (an abscess), which contains dead immune cells, frequently called pus.

Dr. Bragg was involved in all of the surgeries needed to treat the children with abscesses. She said it can be a lengthy process with up to six surgeries, some of which require portions of the skull to be temporarily removed for brain swelling. All of the children either fully recovered or are near full recovery, she said.

Dean Kahn from the UNLV Medical School called it a fortunate and unfortunate situation since Las Vegas and Nevada are lagging in pediatric care without a freestanding children's hospital, as outlined in a News 3 special report.

"One thing that a freestanding children's hospital brings to a community is the wide spectrum of specialists and subspecialists in pediatrics, including a pediatric neurosurgeon," said Kahn. "Unfortunately, we only have one pediatric neurosurgeon for our entire community. Fortunately, she was able to see the patients that we're talking about. But this really does underscore the need for a freestanding children's hospital in our community."

So far, the CDC investigation has not determined the exact cause for the rise in brain abscesses both in Nevada and elsewhere, but there are some theories. Since it's a respiratory illness, COVID infections were considered, but a majority of the patients did not have COVID.

Another consideration is something called "immunity debt," where children didn't build up typical immunities due to social distancing during the pandemic.

"We still don't have a clear answer for what might have potentially caused that within our county," said Dr. Jessica Penney, CDC Epidemic Intelligence Service (EIS) Officer. "But we hope by bringing this to everyone's awareness, we'll be able to continue to work with our local state and federal partners to continue monitoring and research."

Health officials also want to stress that the brain abscesses aren't contagious.

"So the big question that's come up, 'Well, is it the masks? Or 'Should we still be wearing masks?'" said Bragg. "This isn't something that's sitting next to their best friend on the school bus on the way home that they're going to be at risk for developing a sinus infection."

Dr. Bragg said parents do need to keep an eye on their children and take them to the hospital or a doctor should extreme symptoms present themselves.

According to the SNHD health advisory, the median time from symptoms to hospitalization reported was 7.5 days.

Read more from the original source:

Health officials address spike in pediatric brain abscess cases, still considered 'rare' - News3LV

Pediatrics Office Plans Move To Hindman Road – ButlerRadio.com – Butler, PA – butlerradio.com

A local medical provider is planning to build a new and larger facility in Butler Township.

The Butler Township Planning Commission has recommended conditional approval to a land development proposal made by Quick Care Medical for a vacant lot along Hindman Road.

Owners would like to construct a single-story, over 5,000-square foot building for use by a pediatrics practice. The business is currently located in Moraine Pointe Plaza, but has outgrown that space. The new building will also have room for a family practice and a day spa. Some questions about stormwater management remain to be answered.

This proposal will next move on for a vote at the Butler Township Commissioners meeting later this month. If given final approval, work could begin as soon as all necessary permits have been received.

Read the original post:

Pediatrics Office Plans Move To Hindman Road - ButlerRadio.com - Butler, PA - butlerradio.com

Community trauma focus of Pediatrics Community Health and … – University at Buffalo

Physicians training in UBs pediatrics residency program provide care for children at local clinics and at John R. Oishei Childrens Hospital.

They also play key roles advocating for children and families through collaborations with a variety of community organizations. The work of these UB physicians and the organizations they work with will be highlighted at the Community Health and Advocacy Conference taking place from 7:45 a.m. to 1 p.m. May 5 in the atrium of the Jacobs School of Medicine and Biomedical Sciences at UB.

Hosted by the UB pediatrics residency program and the Department of Pediatrics, the event is in person, with a virtual option. Register at this link.

Nearly 100 people from community-based organizations will attend, including individuals from local school districts, community health centers, refugee services, education centers, restorative justice coalitions and many others.

The conference is an effort to create an environment where our pediatric attending physicians, trainees, medical students and other health care professionals can collaborate with community-based organizations around important community health topics, says Sarah J. Ventre, clinical assistant professor of pediatrics in the Jacobs School,physician with UBMD Pediatricsand lead conference organizer.

In light of the traumas our community has faced recently, we felt that trauma prevention was an important topic to focus on and to bring community members together with health care professionals in an interdisciplinary way.

The schedule:

8 to 9 a.m.: Christopher St. Vil, UB assistant professor of social work, will give the grand rounds address, All Hands on Deck: Implementing a Community Violence Intervention Ecosystem in Buffalo, N.Y., Grounded in a Multidisciplinary Approach.

St. Vil will discuss how people in various positions, from physicians to social workers to community members, can address trauma and trauma prevention. He will discuss evidence-based models, including local examples like Buffalo SNUG (Should Never Use Guns) and Buffalo Rising Against Violence (BRAVE).

9 to 10 a.m.: Pediatric residents will do poster presentations on their community health advocacy projects.Topics range from urban gardens, food insecurity, vaccine hesitancy among teens and how to educate providers and the public about child abuse to inspiring children in diverse populations to pursue medicine as a career and diaper equity, the issue around the fact that since there is no exclusive government assistance program to cover the cost of diapers, low-income families are sometimes forced to be more sparing in their use of diapers. That, in turn, creates health problems for the child.

10a.m. to noon: Breaking Down Silos: Finding an Approach to Trauma Prevention That Fits into Your Roles, a panel discussion facilitated by Whitney Mendel, research scientist, Roswell Park Comprehensive Cancer Center. Panelists include Sourav Sengupta, associate professor of psychiatry and pediatrics in the Jacobs School and director of training in adolescent and child psychiatry; Luanne Brown, executive director, Buffalo Prenatal Perinatal Network; and Mia Ayers-Gross, executive director, Most Valuable Parents.

An interactive workshop will follow the panel.

Ventre explains that medical residents in pediatrics are required by the Accreditation Council for Graduate Medical Education to participate in advocacy, which serves to connect pediatricians closely to community organizations.

There may be gaps in care that our families and children are facing that we may not be able to address in 15 minutes in the office, so its our job to work in partnership with community organizations who can help address the systemic issues these families are facing, Ventre says.

And while it might seem that advocacy work is yet another task on top of the often-brutal schedule many pediatricians have, Ventre notes that advocacy work actually turns out to be a positive.

Doing advocacy has been shown to increase wellness and resilience for physicians, she says. It decreases burnout. When you are seeing the same issues over and over and you arent part of the solution, then you are running on a treadmill. But when you are part of the solution and part of fixing things, you feel, This is why I went into medicine.

See the original post here:

Community trauma focus of Pediatrics Community Health and ... - University at Buffalo

American Academy of Pediatrics Names First Chief Health Equity … – American Academy of Pediatrics

Dr. Joseph L. Wright to lead the AAP Equity Agenda and implement a national strategy to promote health equity for all children

ITASCA, IL Joseph L. Wright, MD, MPH, FAAP has been hired by the American Academy of Pediatrics (AAP) to lead and advance the organizations Equity Agenda. He will oversee and implement the Academys national strategy to promote and achieve health equity for all children, as well as efforts for the Academy to become an equitable, diverse and inclusive organization.

Dr. Wright is the first person to serve in the role of Chief Health Equity Officer at AAP. In this role, he will provide strategic guidance to the AAP Board of Directors, the CEO and AAP leadership on all health equity, diversity, and inclusion efforts, integrating clinical, public health and societal perspectives and approaches to improve health and health care disparities.

The AAP has already greatly benefited from Dr. Wrights leadership in many areas, and we are incredibly pleased to now have the opportunity to bring him on board to lead our national equity agenda, said Mark Del Monte, JD, CEO/Executive Vice President of the AAP. This work is crucial and Dr. Wright brings a breadth and depth of knowledge, experience and wisdom that will help AAP make a meaningful impact in the lives of children and families.

Dr. Wright is a former member of the AAP Board of Directors and previous chair of the AAP Board Committee on Equity. His AAP leadership roles have also included chairing the AAP Committee on Pediatric Emergency Medicine and the AAP Task Force on Addressing Bias and Discrimination. Dr. Wright has been recognized by the Academy for his long-standing leadership as recipient of two career achievement awards for distinguished contributions to the disciplines of injury prevention and emergency medicine, and last year was recipient of the inaugural AAP Equity, Diversity, and Inclusion Excellence Award.

Dr. Wright is currently Chief Health Equity Officer of the 12-hospital, 30,000 employee University of Maryland Medical System. He previously served as tenured Professor and Chair of Pediatrics at the Howard University College of Medicine, and as Senior Vice President at the Children's National Hospital, both in Washington, DC. Dr. Wright is a board-certified pediatric emergency physician with scholarly interests that include injury prevention, prehospital pediatrics, and the needs of underserved communities. He has contributed more than 120 publications to the scientific literature, served more than 30 visiting professorships, and was a principal investigator of the NIH-funded DC-Baltimore Research Center on Child Health Disparities. Dr. Wright is an elected member of the Alpha Omega Alpha (medicine) and Delta Omega (public health) honor societies, the American Pediatric Society for which he co-chairs the Committee on Diversity, Inclusion and Equity, and is the 2023 recipient of the Terrapin Award the highest honor conferred by the University of Maryland School of Public Health.

Dr. Wright provides national leadership through advisory and governance service to several health and human service entities including the Association of American Medical Colleges, the March of Dimes, and Safe Kids Worldwide as well as having previously served as an Obama administration appointee to the Pediatric Advisory Committee of the Food and Drug Administration. Dr. Wright earned a B.A. from Wesleyan University in Middletown, CT, his M.D. from Rutgers New Jersey Medical School, and a Master of Public Health in Administrative Medicine and Management from George Washington University.

I am thrilled to join AAP and help to continue the transformative work of ensuring that children and families attain their highest level of health along the path to equity. said Dr. Wright.

Dr. Wright will continue to work with the AAP in a volunteer capacity until he officially assumes the role of Chief Health Equity Officer and Senior Vice President, Equity Initiatives, in September.

###

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit http://www.aap.org or follow us on Twitter @AmerAcadPeds.

Read more:

American Academy of Pediatrics Names First Chief Health Equity ... - American Academy of Pediatrics

Pediatric Oral Immunotherapy Clinic launched | VUMC Reporter … – VUMC Reporter

by Christina Echegaray

Monroe Carell Jr. Childrens Hospital at Vanderbilt has launched a new pediatric Oral Immunotherapy Clinic, which offers a special therapy to peanut-allergic children to reduce risk of a harmful immune response in the event of accidental exposure to peanuts.

Led by Rachel Glick Robison, MD, associate professor of Pediatrics within the Division of Pediatric Allergy, Immunology and Pulmonology, the clinic is located within the Allergy Clinic at Vanderbilt Health One Hundred Oaks.

Around for nearly two decades, oral immunotherapy (OIT) involves a patient eating small, but increasing, amounts of their specific allergen daily over a period until reaching a maintenance level dose. The process is known as desensitization. The maintenance dose is lifelong and must be consumed daily for continued protection.

The most important thing I tell families is that this is not a curative therapy at this point. This is a way to give you a level of protection against accidently ingesting the allergen in your daily life. We know that if you tolerate the therapy amount, then you would tolerate small amounts of the allergen if you were accidentally exposed. They also still have to carry epinephrine injectors, said Robison.

Food allergies affect about 1 in 13 children in the United States. Within that group, about 2.5% of all children have a peanut allergy. That number has steadily risen since 2010, with one study showing that by 2017, there was an estimated 21% increase in peanut allergies in the U.S.

A food allergy is a medical condition in which exposure to certain foods triggers a harmful immune response, which can range from mild (itchiness, hives) to severe or life-threatening (difficulty breathing, throat tightening). The top eight most common food allergies are: peanuts, tree nuts, milk, egg, wheat, soybeans, shellfish and fish.

Each year, about 200,000 people require emergency medical care for allergic reactions to food, according to the organization Food Allergy Research & Education.

OIT, Robison says, offers families the chance to broaden their life activities a bit, lessening some of the apprehension of daily exposure to peanuts for fear of ending up in the emergency room.

If someone has been apprehensive to travel or eat at restaurants, this can provide some benefits for them. Ive also seen people who, as their child gets older and is approaching school age or college, have concerns about accidental ingestion. For those people who really want some protection against accidental ingestion, we know OIT therapy can help provide that.

But OIT isnt for everyone. Robison says she sits down with families for an extensive conversation about all the benefits as well as the risks. She also needs to understand if a child has any other allergic disorders and a familys lifestyle/habits to ensure compliance to the daily dosing regimen. Some people would rather practice avoidance and not have the daily responsibility.

The clinic currently uses the only FDA-approved OIT for peanut allergy, PALFORZIA, which is approved for children ages 4 to 17.

The first couple doses are given in the OIT Clinic under observation. Each level of dosing lasts about two weeks over about six months until the maintenance dose is reached. Currently, the maintenance dose is lifelong.

Robison, who arrived at Vanderbilt in February 2022, previously helped build a food allergy clinical trials program at Lurie Childrens Hospital of Chicago, and she hopes to help develop something similar at Monroe Carell as understanding and therapies for food allergies continues to evolve.

I do believe OIT will likely be done earlier with more regularity and in younger kids at diagnosis, she said. But OIT is not necessarily a perfect fit for every individual, so there is still a lot of room for other options and therapies that are hopefully coming down the pipeline soon.

Read more from the original source:

Pediatric Oral Immunotherapy Clinic launched | VUMC Reporter ... - VUMC Reporter